language_icon
EN
HI

Shilpa Medicare Share price

SHILPAMED

407.8

7.40 (-1.78%)
NSE
BSE
Last updated on 28 Apr, 2026 | 15:51 IST
Today's High

418.50

Today's Low

405.10

52 Week Low

259.50

52 Week High

500.00

Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Shilpa Medicare Chart

Shilpa Medicare Share Key Metrics

Volume
2.80 L
Market Cap
7975.83 CR
LTQ@LTP
1@407.80
ATP
410.03
Var Margin
20.38 %
Circuit Range
332.2-498.2
Delivery %
45.57 %
Value
11.50 CR
ASM/GSM
No
Market Lot
1

Summary

28 Apr, 2026 | 15:51 को, Shilpa Medicare का शेयर प्राइस आज ₹407.8 पर है, जो दिन के लिए 7.40% की -1.78 दर्शाता है। स्टॉक की इंट्राडे मूवमेंट ₹405.10 और ₹418.50 के बीच रही है, जबकि 52‑सप्ताह के आधार पर यह ₹259.50 से ₹500.00 तक रही है। ट्रेडिंग गतिविधि के मामले में, Shilpa Medicare ने 280467 शेयरों का वॉल्यूम रिकॉर्ड किया है, जिसका मार्केट कैपिटलाइज़ेशन ₹195581816 है। स्टॉक की एवरेज ट्रेडेड प्राइस ₹41003 है, जबकि लास्ट ट्रेडेड क्वांटिटी एट लास्ट ट्रेडेड प्राइस (LTQ@LTP) 1,40780 रही। यह स्टॉक ₹332.2-498.2 की सर्किट रेंज में ट्रेड करता है, और आज का कारोबार मूल्य ₹11.50 CR है। दिन के लिए डिलीवरी परसेंटेज 45.57% रही। इसके अतिरिक्त, Shilpa Medicare वर्तमान में No फ्रेमवर्क के तहत आता है और 1 के मार्केट लॉट साइज़ में ट्रेड करता

Shilpa Medicare Fundamentals

View More
P/E Ratio

54.16

P/B Ratio

3.26

Div. Yield

0.12

Sector P/E

64.65

Sector P/B

3.55

Sec. Div. Yield

0.56

Shilpa Medicare Resistance and Support

Pivot 417.07

Resistance

First Resistance

427.14

Second Resistance

439.07

Third Resistance

449.14

Support

First Support

405.14

Second Support

395.07

Third Support

383.14

Shilpa Medicare Shareholding Pattern

View More
  • 2016-17
  • 2018-19
  • 2019-20
  • 2020-21
  • 2021-22
  • 2022-23
  • 2023-24
  • 2024-25
  • 2025-26
  • 2026-27
Total Promoters
Segment
Percent

Total Promoters

53.8%

Mutual Fund

0.17%

Insurance

0%

Foreign Institutional Investors

19.01%

Domestic Institutional Investors

13.17%

Retail

13.85%

Others

0%

Total Promoters
MAR '18
53.8%
JUN '18
53.8%
SEP '18
53.8%
DEC '18
53.8%

Shilpa Medicare Corporate Actions

DateAgenda
2026-02-06Quarterly Results

Shilpa Medicare News

Shilpa Medicare Limited

Shilpa Medicare Limited appointed Dr. Vellaian Karuppiah as Chief Operating Officer, effective April 23, 2026. This appointment aims to strengthen the company's formulation business operations and enhance operational efficiencies, leveraging his 33 years of extensive pharmaceutical experience across R&D, regulatory, and manufacturing.
Apr 23 2026 21:04:00

Shilpa Medicare Limited

Shilpa Medicare appointed Dr. Vellaian Karuppiah as Chief Operating Officer – Formulations, effective April 23, 2026. This appointment aims to strengthen the company's formulation business operations and enhance efficiency, capitalizing on his 33 years of diverse pharmaceutical experience.
Apr 23 2026 09:04:00

Shilpa Medicare Ltd - 530549 - Announcement under Regulation 30 (LODR)-Change in Management

Shilpa Medicare appointed Dr. Vellaian Karuppiah as Chief Operating Officer - Formulations, effective April 23, 2026. This appointment is expected to strengthen the company's formulation business operations and enhance operational efficiencies.
Apr 23 2026 09:04:00

Shilpa Medicare Limited

Shilpa Medicare announced the retirement of Mr. Jayant Karajgi, COO-Formulations, effective April 22, 2026. This marks a leadership change within the senior management team in the formulations segment.
Apr 22 2026 19:04:00

Shilpa Medicare Limited

Shilpa Medicare announced the retirement of Mr. Jayant Karajgi, COO-Formulations, effective April 22, 2026. This marks a leadership change within the senior management team in the formulations segment.
Apr 22 2026 19:04:00

Shilpa Medicare Limited

Shilpa Medicare announced the retirement of Dr. Jayant Karajgi, its Chief Operating Officer - Formulations, effective April 22, 2026. He will cease to be a Senior Management Personnel from this date.
Apr 22 2026 18:04:00

Shilpa Medicare Limited

Shilpa Medicare confirmed it does not qualify as a Large Corporate under SEBI regulations, exempting it from mandatory public debt issuance. The company held an A+ Positive Outlook credit rating from India Ratings & Research in the previous fiscal year.
Apr 09 2026 18:04:00

Shilpa Medicare Limited

Shilpa Medicare's promoter group, along with persons acting in concert, holds 40.13% of total shares (7.84 crore shares) as of March 31, 2026. This includes shares that have been encumbered/pledged.
Apr 06 2026 15:04:00
Read More

About Shilpa Medicare AboutThe

NSE : 17752  
BSE : 530549  
ISIN : INE790G01031  

Shilpa Antibiotics Ltd was incorporated as a PrivateLimited Company in November 1987. The commercialproduction of the Company had started in November 1989.The Company was initially producing Trimethoprim IP/BP anantibiotic bulk drug. The technology for the bulk drug wasdeveloped in house. During the first year of its operationthe Company had installed production facilities tomanufacture Trimethoprim Apart from selling on its own theCompany had also started manufacturing the product forother reputed Companies like Eskayef Limited Bombay Drugsand Pharmas Limited Bombay Drug House Ltd. US VitaminsLtd Sandoz India Ltd etc for their export commitments.During 1992 the Company had installed productionfacilities for manufacture of Sodium Methoxide. Thetechnology for the same had also been developed in house.During the same year the Company secured Export orders fromStellar Exports Limited Glaxo Limited and Deepak NitriteLimited for Trimethoprim. Since then the company hasstarted exporting on its own. The Company thus startedmanufacturing for both export and domestic markets since1992. It has obtained World Health Organisation-GoodManufacturing Practices (GMP) Certificate. It has alsobeen exporting its products to hard currency areas.The Company now proposes to embark upon an expansionproject which involves the addition of one more bulk drugto its existing product range viz; Norfloxcin and expansionof the production capacity of the existing product of theCompany viz; Sodium Methoxide and Trimethoprim. TheCompany also proposes to manufacture 1-MethylAmino-1-Methyl Thio-2-Nitro Ethane a drug intermediateused in the manufacture of Ranitidine an anti-ulcer drug.To raise the necessary resources to finance the expansionproject of the Company the Company was converted into aPublic Limited Company in November 1993.As the company''s sales are comparatively more in theSeptember to March period therefore to reduce theadministrative bottlenecks in the timely preparation ofannual results the company changed its accounting yearfrom March end to September end.Objects of the CompanyThe relevant objects of the company as set out in thememorandum of association of the company are :Main Objects1. To carry on in India or elsewhere the industry trade orbusiness of manufacturers Traders Dealers AgentsSuppliers Licensors Licensees Loan Licenses ImportersExporters Consultants Discoverers Inventors andProducers of Drugs Bulk Drugs PharmaceuticalsPharmaceutical Formulations Alcohol Bended LaboratoryPreparations and general medicinal preparation and ortheir by-products and packing and re-packing of the above.

Read More

Shilpa Medicare Management

NamePosition
Ritu TiwaryCompany Secretary & Compliance Officer
Omprakash InaniChairman
View More

Shilpa Medicare FAQs

Shilpa Medicare शेयर का खरीद मूल्य 407.8 है। लाइव प्राइस और तत्काल ट्रेडिंग के लिए, आप अपने चॉइस ट्रेडिंग खाते में लॉगिन कर सकते हैं या चॉइस के साथ मुक्त डीमैट खाता खोल सकते हैं।

Shilpa Medicare शेयर खरीदने के लिए अपने चॉइस ट्रेडिंग खाते में लॉगिन करें, या चॉइस डीमैट खाता खोल, फिर फंड जोड़ें, कंपनी का नाम खोजें, अपना ऑर्डर टाइप चुनें और ट्रेड प्लेस करें।

Shilpa Medicare शेयर का प्राइस-टू-अर्निंग्स (पी/ई) रेशियो 54.16 है। आप सापेक्ष मूल्यांकन के लिए इसकी तुलना सेक्टर के औसत से कर सकते हैं।

Shilpa Medicare शेयर का प्राइस-टू-बुक (पी/बी) रेशियो 3.26 है। यह शेयर के मूल्य की तुलना उसकी बुक वैल्यू से करने में उपयोगी है।

Shilpa Medicare शेयर का प्राइस-टू-बुक (पी/बी) रेशियो 3.55 है। यह शेयर के मूल्य की तुलना उसकी बुक वैल्यू से करने में उपयोगी है।

Shilpa Medicare का मार्केट कैप 7975.83 CR है। यह कंपनी के आकार की श्रेणी और ट्रेडिंग लिक्विडिटी को दर्शाता है।

Shilpa Medicare शेयर का 52 सप्ताह का उच्चतम और न्यूनतम मूल्य 500.00 और 259.50 है। ये मूल्य मूल्य सीमाएं, ट्रेडिंग रेंज, अस्थिरता, संभावित सपोर्ट/रेजिस्टेंस और मूल्य गति को दर्शाते हैं।

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost